Fri 2/21/2020 11:43 ET
DJIA29032.10185.810.64%TELCO190.930.530.28%GOLD1642.1521.681.32%Shanghai3044.1114.000.46%
S&P 5003346.2826.770.80%BANKS496.246.601.33%OIL53.180.701.32%BITCOIN9703.7498.011.01%
NASDAQ9634.06115.611.20%PHARM614.291.470.24%US/EU1.090.000.01%Futures3346.1223.090.69%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Wall Street Pit (Genprex - GNPX)    Stock Due Diligence for All

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add GNPX
  
From: NetworkNewsWire (Rep: 0)Date: 02/14/2020 15:48
Forum: Wall Street Pit - Msg #2816419 - List GNPX msgs Thread #674123372 (Rec: 0)
NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Inks Exclusive License Agreement with University of Pittsburgh for Diabetes Gene Therapy

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and other serious diseases, recently announced its entry into an exclusive license agreement with the University of Pittsburgh for a diabetes gene therapy that may have the potential to cure Type 1 and Type 2 diabetes, which together currently affect approximately 30.3 million people in the U.S., or 9% of the U.S. population. According to the update, Genprex’s licensed diabetes gene therapy technology is designed to reprogram alpha cells in the pancreas into beta-like cells, restoring their function, thereby replenishing insulin levels. “We are excited to announce the licensing agreement with The University of Pittsburgh, and we look forward to working with Dr. Gittes and his team to develop this groundbreaking treatment for diabetes,” Genprex’s Chairman and Chief Executive Officer Rodney Varner said in the news release. “At Genprex, we have always put patient needs first, focusing on ways to bring new treatment options to patient populations who have large unmet medical needs. We believe this diabetes gene therapy may potentially become a new treatment option for the millions of diabetes patients who now must take insulin replacement therapy, and it may be effective for patients who do not benefit sufficiently from that therapy. Even more moving, the diabetes gene therapy could hold the potential to provide long term effectiveness, or even be a cure, for diabetes patients.”

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser NetworkNewsWire: Reward | Watch | IgnoreGNPX: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add GNPX
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.